Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.


  • Physical activity linked to better memory among older adults

  • Mosquito-borne virus may lead to severe brain infection

  • Marijuana dependence influenced by genes, childhood sexual abuse

  • Thinking of bagging yourself a Black Friday bargain?

  • Synapse discovery could lead to new treatments for Alzheimer's disease

  • And when the bubbles burst, thunder in neurons

  • Better detection of concussion in young football players

  • Structural brain connectivity as a genetic marker for schizophrenia

  • Peak-end pizza: Higher prices mean first impressions count

  • Can physical exercise enhance long-term memory?